Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Opinion in Biotechnology is Scopus-indexed (Q1, CiteScore 17.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 0958-1669Verify ISSN ↗1879-0429Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: About US$4,530 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 18 / 325 | 94th | Q1 |
| Biomedical Engineering | 22 / 342 | 93rd | Q1 |
| Bioengineering | 15 / 168 | 91st | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1990–present, best quartile Q1, CiteScore 17.3.
Current Opinion in Biotechnology is Q1 in Biotechnology (rank 18 of 325), Q1 in Biomedical Engineering (rank 22 of 342) and Q1 in Bioengineering (rank 15 of 168), by CiteScore 2025.
Current Opinion in Biotechnology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 17.3, which places it in quartile Q1 at the 94th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.983, quartile Q1, with an H-index of 261.
The publisher lists an article processing charge of about US$4,530 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Current Opinion in Biotechnology is published by Elsevier Ltd. Its print ISSN is 0958-1669 and its online ISSN is 1879-0429.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Opinion in Biotechnology has an h-index of 290 and a 2-year mean of 8.41 citations per paper (OpenAlex). Its Scopus CiteScore is 17.3, quartile Q1. On 2-year citations it ranks #21 of 309 Scopus journals in Biotechnology.
Current Opinion in Biotechnology published 124 papers in 2025; its busiest recent year was 2021 with 220. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (25.3%), United States (17.1%) and South Korea (10.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.